Cargando…
Tumor endothelial marker 8 promotes cancer progression and metastasis
Every year more than 8 million people suffer from cancer-related deaths worldwide [1]. Metastasis, the spread of cancer to distant sites, accounts for 90% of these deaths. A promising target for blocking tumor progression, without causing severe side effects [2], is Tumor Endothelial Marker 8 (TEM8)...
Autores principales: | Høye, Anette M., Tolstrup, Sofie D., Horton, Edward R., Nicolau, Monica, Frost, Helen, Woo, Jung H., Mauldin, Jeremy P., Frankel, Arthur E., Cox, Thomas R., Erler, Janine T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059023/ https://www.ncbi.nlm.nih.gov/pubmed/30046396 http://dx.doi.org/10.18632/oncotarget.25734 |
Ejemplares similares
-
The role of lysyl oxidase, the extracellular matrix and the pre-metastatic niche in bone metastasis()()
por: Gartland, Alison, et al.
Publicado: (2016) -
LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling
por: Chang, Joan, et al.
Publicado: (2013) -
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
por: Cox, Thomas R., et al.
Publicado: (2011) -
Organ-Specific, Fibroblast-Derived Matrix as a Tool for Studying Breast Cancer Metastasis
por: Jensen, Adina R. D., et al.
Publicado: (2021) -
Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis
por: Madsen, Chris D, et al.
Publicado: (2015)